Daniel A. Hammer
Inaugural Director, Penn Center for Precision Engineering for Health
Alfred G. and Meta A. Ennis Professor of Bioengineering, University of Pennsylvania
Research Focus
The Hammer laboratory works in two major areas: quantitative immunology and protocell design. It develops methods and models for studying immune cell function, such as adhesion and motility, and how these processes can be manipulated in cell therapy, such as CAR T cell therapy. The laboratory is also developing synthetic cells (protocells) that display autonomous motility, and is developing methods for building architectures of synthetic cells, such as membranes made from novel surfactants and membraneless organelles from coacervating proteins.
Education
B.S.E. Chemical Engineering, Princeton University, 1982
Ph.D. Chemical Engineering, University of Pennsylvania, 1987
Awards
1987 NSF Presidential Young Investigator Award
2006 BMES Distinguished Lectureship Award
2018 Penn Provost Award for Ph.D. Advising and Teaching
Xue (Sherry) Gao
Associate Professor of Chemical and Biomolecular Engineering, University of Pennsylvania
Secondary Appointment in Bioengineering, University of Pennsylvania
Core Faculty, Penn Center for Precision Engineering for Health
Research Focus
The Gao laboratory is dedicated to advancing the development of highly specific and potent genome-editing tools with broad applications in disease treatment, diagnostics, and the exploration of novel small-molecule drugs. Our research focuses on the engineering of precision and multiplex CRISPR genome-editing techniques, which not only offer a safe and effective approach to addressing genetic disorders but also hold promise for engineering microbial and plant genomes, enabling the production of innovative small molecules with therapeutic potential. In addition to our genome-editing efforts, our laboratory is at the forefront of engineering ultrasensitive viral detection systems. By leveraging enhanced CRISPR systems, we aim to significantly improve the accuracy and timeliness of viral diagnostic methods, particularly in the context of pandemics and epidemics. Our mission is to contribute to cutting-edge research that has the potential to revolutionize molecular therapy, genetic engineering, and diagnostics, ultimately benefiting healthcare and biotechnology industries.
Education
B.S. Pharmaceutical Engineering, Tianjin University, 2005
M.S. Pharmaceutical Engineering, Tianjin University, 2007
Ph.D. Chemical and Biomolecular Engineering, University of California, Los Angeles, 2013
Awards
2020 NIH Maximizing Investigators’ Research Award
2022 NSF CAREER Award
2022 Invitee to US-China Frontiers of Engineering Symposium, National Academy of Engineering
2024 BMES Cellular and Molecular Bioengineering (CMBE) Rising Star Award
David Issadore
Professor of Bioengineering, University of Pennsylvania
Secondary Appointments in Electrical and Systems Engineering, Chemical and Biomolecular Engineering, and Mechanical Engineering and Applied Mechanics, University of Pennsylvania
Core Faculty, Penn Center for Precision Engineering for Health
Research Focus
The Issadore lab combines microelectronics, microfluidics, nanomaterials, and machine learning to solve big problems in healthcare. We create miniaturized platforms for the diagnosis of disease, we develop new platforms to manufacture micro and nanomaterials, and we dip our toes into an assortment of other areas where we can leverage our engineering training to improve healthcare. This work requires an interdisciplinary approach in which engineers, scientists, and physicians work together in teams.
Education
B.S. Physics and B.S. Electrical Engineering, Schreyer’s College at Penn State University, 2004
Ph.D. Applied Physics, Harvard University, 2009
Awards
2014 S. Reid Warren, Jr. Award, in recognition of outstanding service in stimulating and guiding the intellectual and professional development of undergraduate students
2016 National Science Foundation CAREER Award
2023 Pioneer in Miniaturization Lectureship
Yuanwen Jiang
Assistant Professor of Materials Science and Engineering, University of Pennsylvania
Core Faculty, Penn Center for Precision Engineering for Health
Research Focus
The Jiang Group is an interdisciplinary team working in the field of bioelectronics, with people from materials science, molecular engineering, and biomedical engineering backgrounds. Through fundamental innovations in material design and device fabrication, we are passionate about transforming breakthroughs in physical sciences and engineering into novel tools to address unmet medical needs.
Education
B.S. Chemistry, Nanjing University, 2012
Ph.D. Chemistry, University of Chicago, 2018
Awards
2018 IUPAC-SOLVAY International Award for Young Chemists
2018 ACS Young Investigator Symposium Award
2021 Baxter Young Investigator Award
Christopher M. Madl
Assistant Professor of Materials Science and Engineering, University of Pennsylvania
Core Faculty, Penn Center for Precision Engineering for Health
Research Focus
The Madl laboratory develops new hydrogel materials to study the role of biophysical cues from the extracellular environment on tissue dysfunction in aging and disease. The lab employs protein engineering and stimuli-responsive bioorthogonal chemistries to make materials with on-demand tuning of mechanical and microstructural cues. The lab is particularly interested in how altered mechanical signals in aged skeletal muscle and nervous system tissues lead to impaired cellular function.
Education
B.A. Engineering Sciences, Harvard University, 2012
M.S. Engineering Sciences, Harvard University, 2012
Ph.D. Bioengineering, Stanford University, 2017
Awards
2015 NIH NRSA Predoctoral Fellowship (F31)
2016 Siebel Scholars Class of 2017
2019 Life Sciences Research Foundation (LSRF) Postdoctoral Fellowship
2021 NIH K99/R00 Pathway to Independence Award
David F. Meaney
Senior Associate Dean, Penn Engineering
Solomon R. Pollack Professor of Bioengineering, University of Pennsylvania
Core Faculty, Penn Center for Precision Engineering for Health
Research Focus
Concussion is highly prevalent. Unfortunately, treatments for concussion are not. As a team, The Molecular Neuroengineering Lab studies concussion (aka mild traumatic brain injury) with a variety of methods and tools that include in vivo, in vitro, and in silico models of injury. Leveraging diverse modalities gives them a unique ability to draw connections between injury-induced changes that occur at various spatial scales, ranging from the individual cell to the neuronal circuit to the whole brain. With this knowledge, they can develop and test novel strategies to prevent and mitigate concussion.
Education
B.S.E. Biomedical Engineering, Rensselaer Polytechnic Institute, 1987
M.S.E. Bioengineering, University of Pennsylvania, 1989
Ph.D. Bioengineering, University of Pennsylvania, 1991
Awards
1998 National Science Foundation CAREER Award
2001 American Society of Mechanical Engineering YC Fung Young Investigator Award
2014 Trustees’ Council of Penn Women Provost’s Award
Michael Mitchell
Associate Professor of Bioengineering, University of Pennsylvania
Group Leader, Lipid Nanoparticle Delivery Systems, Penn Institute for RNA Innovation
Director, Lipid Nanoparticle Synthesis Core, Penn Institute for RNA Innovation
Core Faculty, Penn Center for Precision Engineering for Health
Research Focus
Michael J. Mitchell is an Associate Professor of Bioengineering at the University of Pennsylvania, and the Lipid Nanoparticle Delivery Systems Group Leader at the Penn Institute for RNA Innovation. He received a BE in Biomedical Engineering from Stevens Institute of Technology in 2009, a PhD in Biomedical Engineering with Prof. Michael King from Cornell University in 2014. He was a Postdoctoral Fellow in Chemical Engineering with Prof. Robert Langer at MIT from 2014-2017, prior to pursuing his independent career at University of Pennsylvania in 2018. The Mitchell lab’s research broadly lies at the interface of biomaterials science, drug delivery, and cellular and molecular bioengineering to fundamentally understand and therapeutically target biological barriers. Specifically, his lab engineers new lipid and polymeric nanoparticle platforms for the delivery of different nucleic acid modalities to target cells and tissues across the body. His lab applies their research findings and the technologies developed to a range of human health applications, including the engineering of CAR T cells for cancer immunotherapy, mRNA vaccines, genome editing, cardiovascular disease, and in utero therapeutics to treat disease before birth.
Mitchell has received numerous awards as an independent investigator, including the National Institutes of Health Director’s New Innovator Award, the Rising Star Award from the Biomedical Engineering Society, the Career Award at the Scientific Interface from the Burroughs Wellcome Fund, and the Research Scholar Award from the American Cancer Society. In 2022 Mitchell was named “Emerging Inventor for the Year” by Penn’s for Innovation in recognition for his lipid nanoparticle technologies and received the Young Investigator Award from the Society for Biomaterials, the T. Nagai Award from the Controlled Release Society, the National Science Foundation CAREER Award, and was named a 2023 Young Innovator in Cellular and Molecular Bioengineering. He is a co-founder of Liberate Bio, a biotechnology company focused on developing non-viral delivery technologies for genetic medicines, and serves on the Scientific Advisory Board of numerous biotechnology companies.
Education
B.E. Biomedical Engineering, Stevens Institute of Technology, 2009
M.E. Materials Science and Engineering, Stevens Institute of Technology, 2009
M.S. Biomedical Engineering, Cornell University, 2012
Ph.D. Biomedical Engineering, Cornell University, 2014
Awards
2014-2017 NIH NCI Ruth L. Kirschstein Postdoctoral Fellowship (F32), National Cancer Institute
2017 Burroughs Wellcome Fund Career Award at the Scientific Interface
2018 National Institutes of Health Director’s New Innovator Award
2019 Controlled Release Society T. Nagai Award
2021 Emerging Inventor of the Year, Penn Center for Innovation
2022 National Science Foundation CAREER Award
2022 Society for Biomaterials Young Investigator Award
2023 Cellular and Molecular Bioengineering Young Innovator Award
Noor Momin
Stephenson Foundation Term Assistant Professor of Innovation, University of Pennsylvania
Core Faculty, Penn Center for Precision Engineering for Health
Research Focus
The Momin lab investigates the immune system in cardiovascular diseases including heart failure, atherosclerosis, and arrhythmia. We seek to develop novel diagnostics and treatments for these diseases by leveraging our understanding of cardiovascular immunology, protein engineering, and pharmacokinetic modeling.
Education
B.S. Biomedical Engineering, University of Texas at Austin, 2015
Ph.D. Biological Engineering, Massachusetts Institute of Technology, 2021
Awards
2021 National Siebel Scholar in Bioengineering
Yihui Shen
Assistant Professor of Bioengineering, University of Pennsylvania
Core Faculty, Penn Center for Precision Engineering for Health
Research Focus
The Shen laboratory works at the interface of optical imaging and systems biology of metabolism. We aim to innovate tools for metabolic measurement at single cell level, and to apply them to probe metabolism in tissue, tumor, and microbial communities. We are also interested in how metabolic programs are controlled to support immune cell proliferation and function, and how that is impacted by tumor microenvironment.
Education
B.A. Chemistry, Peking University, 2012
Ph.D. Chemistry, Columbia University, 2017
Awards
HHMI International Student Research Fellowship